explore -WSS

explore

author：entertainment 2025-08-19 12:15:10 - browse：52861

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Mayo Clinic plans $5B tech

hotspot

WSS

Experts study whether long Covid risk adds up with each reinfection

FDA panel to weigh approval of NurOwn, controversial ALS drug

Drug for rare kidney disease narrowly misses mark in clinical trial

Cigna, Humana reportedly in talks to merge

Takeda, Janssen join wearable maker to measure scratching

Drug for rare kidney disease narrowly misses mark in clinical trial

entertainment

explore

knowledge

In Memoriam: Notable people who died in 2023

U.K. Biobank has 500,000 peoples' genome sequences available

23andMe had bad news about my health. I wish a person had delivered it

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Alkermes shareholders re

Readout LOUD podcast: possible new ALS drug, artificial wombs

Heart attack and stroke risk calculators need revising

CDC's new outbreak response network to include Northeastern

Hollywood unions extend contract negotiations for actors

30 years of 'Listening to Prozac'

hotspot

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Takeda, Janssen join wearable maker to measure scratching

Medical student insurance fails on mental health care coverage

Hearing on Medicare drug price negotiation gets unusually heated

CDC director unscathed in first congressional testimony

Medical student insurance fails on mental health care coverage

hotspot

explore

hotspot

focus